BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36548103)

  • 1. Overactive Bladder Patients With and Without Urgency Incontinence: A Spectrum of One Condition or Different Phenotypes?
    Torosis M; Jackson N; Nitti V; Ackerman AL
    Urogynecology (Phila); 2023 Jan; 29(1):33-40. PubMed ID: 36548103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofascial Frequency Syndrome: A novel syndrome of bothersome lower urinary tract symptoms associated with myofascial pelvic floor dysfunction.
    Ackerman AL; Jackson NJ; Caron AT; Kaufman MR; Routh JC; Lowder JL
    medRxiv; 2023 Apr; ():. PubMed ID: 37131628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the elements of overactive bladder: questions raised by the EPIC study.
    Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K;
    BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
    Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
    J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.
    Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C
    BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms.
    Sacco E; D'Addessi A; Racioppi M; Pinto F; Totaro A; Bassi P
    Int J Gynaecol Obstet; 2012 May; 117(2):168-72. PubMed ID: 22361478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Persistency Index: a novel screening tool for identifying myofascial pelvic floor dysfunction in patients seeking care for lower urinary tract symptoms.
    Ackerman AL; Torosis M; Jackson NJ; Caron AT; Kaufman MR; Lowder JL; Routh JC
    Am J Obstet Gynecol; 2023 Dec; 229(6):667.e1-667.e11. PubMed ID: 37633575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of models predicting treatment patterns in women with urinary urgency and/or urgency incontinence: A Symptoms of Lower Urinary Tract Dysfunction Research Network observational cohort study.
    Bretschneider CE; Liu Q; Smith AR; Mansfield SA; Kirkali Z; Amundsen CL; Lai HHH; Geynisman-Tan J; Kirby A; Jelovsek JE;
    Neurourol Urodyn; 2023 Aug; 42(6):1214-1226. PubMed ID: 37269483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the real burden of the overactive bladder? Results from a national prevalence study.
    Santander J; Plata M; Zuluaga L; Azuero J; Daza F; Trujillo CG; Caicedo JI; Rondón M
    Neurourol Urodyn; 2022 Apr; 41(4):926-934. PubMed ID: 35233807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
    Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
    BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns in women with urinary urgency and/or urgency urinary incontinence in the symptoms of Lower Urinary Tract Dysfunction Research Network Observational Cohort Study.
    Bretschneider CE; Liu Q; Smith AR; Kirkali Z; Amundsen CL; Lai H; Geynisman-Tan J; Kirby A; Cameron AP; Helmuth ME; Griffith JW; Jelovsek JE;
    Neurourol Urodyn; 2023 Jan; 42(1):194-204. PubMed ID: 36579974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Overactive Bladder-Wet Syndrome on Female Sexual Function: A Systematic Review and Meta-Analysis.
    Balzarro M; Rubilotta E; Mancini V; Trabacchin N; Oppezzi L; Li Marzi V; Fusco F; Serati M
    Sex Med Rev; 2019 Oct; 7(4):565-574. PubMed ID: 31326358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS.
    Milsom I; Kaplan SA; Coyne KS; Sexton CC; Kopp ZS
    Urology; 2012 Jul; 80(1):90-6. PubMed ID: 22748867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population.
    Lai HH; Shen B; Rawal A; Vetter J
    BMC Urol; 2016 Oct; 16(1):60. PubMed ID: 27716241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can surgical reconstruction of vaginal and ligamentous laxity cure overactive bladder symptoms in women with pelvic organ prolapse?
    Liedl B; Goeschen K; Sutherland SE; Roovers JP; Yassouridis A
    BJU Int; 2019 Mar; 123(3):493-510. PubMed ID: 29908047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the effect of overactive bladder symptoms on woman's quality of life during and after first pregnancy?
    Van Brummen HJ; Bruinse HW; Van de Pol G; Heintz AP; Van der Vaart CH
    BJU Int; 2006 Feb; 97(2):296-300. PubMed ID: 16430633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.